Caliway Biopharmaceuticals , Ltd. PEG Ratio

As of the most recent data, 6919.TWO shows a PEG ratio of 1184.57. That is above the Healthcare sector average of 27.75. Scroll down for historical charts and peer comparison views.

The Healthcare sector average PEG ratio is about 27.75. Caliway Biopharmaceuticals , Ltd. is at 1184.57, which is higher that average. That is roughly 4168.5% above the sector mean. Use the comparison chart on this page to see how 6919.TWO stacks up against individual peers as well.

Investors watch 6919.TWO's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Caliway Biopharmaceuticals , Ltd.'s latest reading is 1184.57. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this peg ratio page, Stockcircle has Caliway Biopharmaceuticals , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 1184.57) with ownership activity and broader fundamentals.

The Healthcare average PEG ratio is about 27.75, while 6919.TWO is at 1184.57. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.